Proteon logo     Print Page | Close Window

SEC Filings

PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document

Table of Contents

      "Capitalization—Series D Convertible Preferred Stock" for applicable conversion price adjustments;

    a one-for-      reverse stock split of our common stock to be effected on                  , 2014 prior to completion of this offering;
    no exercise of stock options on or after August 31, 2014; and
    no exercise by the underwriters of their option to purchase up to a total of                additional shares of common stock in this offering.